Evicenter
P&T meetings

Dersimelagon (MT-7117)

Erythropoietic protoporphyria or X-linked protoporphyria

Manufacturer
LEO Pharma
Regulatory submission
NDA submitted June 2026
Last updated
100 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Erythropoietic protoporphyria or X-linked protoporphyria

Economic impact of Erythropoietic protoporphyria or X-linked protoporphyria on families

3 evidence topics · 3 sources

Quantified family out-of-pocket costs and caregiver productivity loss

No evidence found.